VANESSA BULLARD: Open Payments
NPI 1962946467 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 17 payments from 12 companies in 2025. Trend: 2023 $1,407 · 2024 $742 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $51 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $25 |
| CARDIVA MEDICAL, INC. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| SCPHARMACEUTICALS INC. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: WATCHMAN, VERQUVO, FARXIGA, JARDIANCE, LifeVest, CARDIVA VASCADE MVP XL VVCS 10-12F, NEXLETOL, MCOT.
Industry payments across FL — which companies pay providers there.
